AdamSCheifetzMD
Gastroenterology • Boston, MAInflammatory Bowel Disease
Director, Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center; Professor of Medicine, Harvard Medical School
Dr. Cheifetz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
330 Brookline Ave
Beth Israel Deaconess Medical Center
Boston, MA 02215Phone+1 617-667-2082- Is this information wrong?
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2003 - 2004
Yale-New Haven Medical CenterFellowship, Gastroenterology, 2001 - 2004- Yale-New Haven Medical CenterResidency, Internal Medicine, 1997 - 2000
Weill Cornell MedicineClass of 1997
Certifications & Licensure
MA State Medical License 2004 - 2025
CT State Medical License 2000 - 2005- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2008-2013
- Fellow (AGAF) American Gastroenterological Association, 2012
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- Sexual Health in Sexual and Gender Minority Patients with Inflammatory Bowel Disease.Chedid, V., Andrew Eidelberg, Jordan Axelrad, Victor Chedid, Sarah Ballou, Adam Cheifetz, Loren G Rabinowitz> ;Digestive Diseases and Sciences. 2024 Mar 1
- 1 citationsDrug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics.Tina Deyhim, Adam S Cheifetz, Konstantinos Papamichael> ;Journal of Clinical Medicine. 2023 Nov 16
- 4 citationsPatients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.Andres J Yarur, Maria T Abreu, Parakkal Deepak, Poonam Beniwal-Patel, Konstantinos Papamichael, Byron Vaughn, Alexandra Bruss, Shaina Sekhri, Andrea Moosreiner, Philli...> ;The American Journal of Gastroenterology. 2023 Nov 1
- Join now to see all
Journal Articles
- Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel DiseaseByron P Vaughn, Adam S Cheifetz, Digestive Diseases and Sciences
Lectures
- Advances in Gastroenterology - 2013Harvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 6/10/2013
- Gastroenterology in the 21st Century: Optimizing Patient OutcomesOMICS Publishing Group, Boston, Massachusetts - 5/7/2013
Other
- Sulfasalazine and 5-aminosalicylates in the treatment of inflammatory bowel diseaseCheifetz AS, Cullen GJ
http://www.uptodate.com/contents/sulfasalazine-and-5-aminosalicylates-in-the-treatment-of-inflammato
UpToDate, Wolters Kluwer Health - 2012-12-06
Press Mentions
Dealing with Crohn's Disease During PregnancyJuly 28th, 2020- Top in GI: Telehealth, IBD Treatment SelectionJuly 24th, 2020
- Bacainn Therapeutics Announces IND Clearance for BT051 and Initiation of Phase 1 Clinical Trial, Bacainn’s First Clinical Candidate for the Treatment of Ulcerative ColitisJune 9th, 2020
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Hospital Affiliations
Beth Israel Deaconess Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
